A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
European Myeloma Network B.V.
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Dana-Farber Cancer Institute
Celgene
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
University of Arkansas
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
University of Arkansas
University of Arkansas
University of Arkansas
University of Arkansas
City of Hope Medical Center
European Myeloma Network B.V.
Amsterdam UMC, location VUmc
Cancer Trials Ireland
University of Turin, Italy
University of Leeds
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Roswell Park Cancer Institute
University of Leeds
Celyad Oncology SA